Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market Growth, Share, Size, Trends and Forecast (2024 - 2030)
Segmented by Pipeline Therapeutics;
Obeticholic Acid (OCA), Aramchol (arachidyl amido cholanoic acid), Saroglitazar and Elafibranor.Segmented by Diagnostic Technique;
Imaging - Ultrasonography (US), Computed Tomography (CT), Magnetic Resonance Imaging (MRI) and Others, Liver Biopsy and Biomarker diagnostics - Serum Biomarkers, Hepatic Fibrosis Biomarkers, Apoptosis Biomarkers, Oxidative Stress Biomarker and Others, Others.Segmented by Therapeutics Technique;
Pharmacologic Therapy, Steatosis/insulin Resistance, Anti-Cytokines and Surgical Interventions.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).Introduction
Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market (USD Million), 2020 - 2030
# | Global |
---|---|
2020 | 91.5 |
2021 | 103.4 |
2022 | 113.3 |
2023 | 119.4 |
2024 | 140.9 |
2025 | 152.3 |
2026 | 154.4 |
2027 | 154.6 |
2028 | 184.0 |
2029 | 220.2 |
2030 | 250.3 |
In the year 2023, the Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market was valued at USD 27,591.88 million. The size of this market is expected to increase to USD 138,267.45 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 25.9%.
Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market Report Snapshot
Parameters | Description |
---|---|
Market | Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market |
Study Period | 2020 - 2030 |
Base Year (for Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market Size Estimates) | 2023 |
Study Scope |
|
Market Segmentation |
|
Geographical Coverage |
|
Company Coverage |
|
Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics nonalcoholic steatohepatitis Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market Analysis
In this report, the Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market has been segmented by Pipeline Therapeutics, Diagnostic Technique, Therapeutics Technique and Geography.
Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market, Segmentation by Pipeline Therapeutics
The Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market has been segmented by Pipeline Therapeutics into Obeticholic Acid (OCA), Aramchol (arachidyl amido cholanoic acid), Saroglitazar and Elafibranor . The complete Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market segmentation by Pipeline Therapeutics can be seen below:
- Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market, By Pipeline Therapeutics
- Obeticholic Acid (OCA)
- Aramchol (arachidyl amido cholanoic acid)
- Saroglitazar
- Elafibranor
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Pipeline Therapeuticss mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Pipeline Therapeutics is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market, by Pipeline Therapeutics (USD Million), 2020 - 2030
# | Obeticholic Acid (OCA) | Aramchol (arachidyl amido cholanoic acid) | Saroglitazar | Elafibranor |
---|---|---|---|---|
2020 | 55.9 | 109.7 | 58.0 | 69.4 |
2021 | 60.8 | 131.6 | 61.2 | 70.4 |
2022 | 71.0 | 154.7 | 71.1 | 82.2 |
2023 | 78.8 | 156.5 | 83.0 | 92.9 |
2024 | 82.8 | 161.6 | 99.2 | 100.8 |
2025 | 94.4 | 165.2 | 102.5 | 111.7 |
2026 | 103.6 | 187.8 | 111.2 | 132.0 |
2027 | 119.8 | 219.3 | 117.7 | 140.5 |
2028 | 128.5 | 255.3 | 129.9 | 161.2 |
2029 | 149.7 | 306.0 | 134.1 | 169.2 |
2030 | 174.7 | 348.5 | 138.3 | 175.9 |
Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market, Segmentation by Diagnostic Technique
The Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market has been segmented by Diagnostic Technique into Imaging, Liver Biopsy, Biomarker diagnostics and Others. The complete Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market segmentation by Diagnostic Technique can be seen below:
- Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market, By Diagnostic Technique
- Imaging
- Ultrasonography (US)
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Others
- Liver Biopsy
- Biomarker diagnostics
- Serum Biomarkers
- Hepatic Fibrosis Biomarkers
- Apoptosis Biomarkers
- Oxidative Stress Biomarker
- Others
- Others
- Imaging
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Diagnostic Techniques mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Diagnostic Technique is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market, by Diagnostic Technique (USD Million), 2020 - 2030
# | Imaging | Liver Biopsy | Biomarker diagnostics | Others |
---|---|---|---|---|
2020 | 92.4 | 92.3 | 114.5 | 58.0 |
2021 | 106.6 | 102.1 | 117.2 | 63.8 |
2022 | 127.7 | 117.5 | 131.0 | 71.0 |
2023 | 139.9 | 131.8 | 147.2 | 72.7 |
2024 | 150.0 | 142.3 | 158.3 | 78.5 |
2025 | 168.7 | 165.9 | 173.2 | 84.9 |
2026 | 190.4 | 192.9 | 191.2 | 88.8 |
2027 | 217.8 | 214.1 | 204.8 | 94.7 |
2028 | 220.6 | 252.7 | 217.9 | 99.3 |
2029 | 247.2 | 278.8 | 261.0 | 100.5 |
2030 | 256.9 | 287.8 | 309.2 | 107.9 |
Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market, Segmentation by Therapeutics Technique
The Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market has been segmented by Therapeutics Technique into Pharmacologic Therapy, Steatosis/insulin Resistance, Anti-Cytokines and Surgical Interventions. The complete Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market segmentation by Therapeutics Technique can be seen below:
- Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market, By Therapeutics Technique
- Pharmacologic Therapy
- Steatosis/insulin Resistance
- Anti-Cytokines
- Surgical Interventions
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Therapeutics Techniques mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Therapeutics Technique is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market, by Therapeutics Technique (USD Million), 2020 - 2030
# | Pharmacologic Therapy | Steatosis/insulin Resistance | Anti-Cytokines | Surgical Interventions |
---|---|---|---|---|
2020 | 87.6 | 92.6 | 70.2 | 62.4 |
2021 | 102.8 | 97.9 | 72.6 | 74.3 |
2022 | 107.2 | 103.2 | 78.2 | 76.0 |
2023 | 111.4 | 112.6 | 83.8 | 83.0 |
2024 | 113.1 | 118.2 | 97.3 | 97.9 |
2025 | 124.8 | 127.9 | 109.5 | 115.4 |
2026 | 133.2 | 141.2 | 129.1 | 122.5 |
2027 | 156.3 | 162.0 | 133.2 | 139.8 |
2028 | 179.5 | 164.8 | 150.9 | 160.0 |
2029 | 205.8 | 196.6 | 165.8 | 180.4 |
2030 | 234.6 | 228.7 | 183.9 | 186.4 |
Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market, Segmentation by Geography
In this report, the Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market Share (%), by Geographical Region, 2023
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market in all the Regions and Countries (specified above) for historic (2020 - 2023) and forecast (2024 - 2030) Periods with 2023 considered as the base year.
This report also provides an analysis of why the market size of Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The factors driving the growth of Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market will be discussed in detail in the full report.
- The factors hindering the growth of Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market will be discussed in detail in the full report.
- The new opportunities in Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market will be discussed in detail in the full report.
- Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market Drivers will be discussed in detail in the full report.
- Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market Restraints will be discussed in detail in the full report.
- Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market Opportunities will be discussed in detail in the full report.
Market Opportunity Map
This report provides market opportunity map for Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market. The opportunity map (by market segments; Pipeline Therapeutics, Diagnostic Technique and Therapeutics Technique) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market, Opportunity Map, By Region (2020 - 2030)
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics nafld nash Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value. Approximately half of patients with nash who were treated with vitamin e or pioglitazone saw improvement.
Bargaining Power of Suppliers
Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
---|---|---|---|---|
10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
---|---|---|---|---|
20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
---|---|---|---|---|---|
2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
---|---|---|---|---|
5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market include, AstraZeneca PLC, Conatus Pharmaceuticals, Inc., Enzo Biochem, Inc., Galmed Pharmaceuticals Ltd, Genfit Corp., Gilead, Horizon Pharma PLC, Immuron, Intercept Pharmaceuticals and Novo Nordisk A/S.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
---|---|---|---|---|---|---|---|---|---|---|
Product 1/Service 1 | ||||||||||
Product 2/Service 2 | ||||||||||
Product 3/Service 3 | ||||||||||
Product 4/Service 4 | ||||||||||
Product 5/Service 5 | ||||||||||
Product 6/Service 6 | ||||||||||
Product 7/Service 7 | ||||||||||
Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Pipeline Therapeutics
- Market Snapshot, By Diagnostic Technique
- Market Snapshot, By Therapeutics Technique
- Market Snapshot, By Region
- Market Opportunity Map
- Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Restraints
- Opportunities
- Regulatory Scenario
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Obeticholic Acid (OCA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Aramchol (arachidyl amido cholanoic acid)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Saroglitazar
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Elafibranor
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Obeticholic Acid (OCA)
- Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Imaging
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Ultrasonography (US)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Computed Tomography (CT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Magnetic Resonance Imaging (MRI)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Ultrasonography (US)
- Liver Biopsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Biomarker diagnostics
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Serum Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Hepatic Fibrosis Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Apoptosis Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Oxidative Stress Biomarker
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Serum Biomarkers
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Imaging
- Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market, By Therapeutics Technique, 2020 - 2030 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Pharmacologic Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Steatosis/insulin Resistance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Anti-Cytokines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Surgical Interventions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Pharmacologic Therapy
- Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market, By Geography, 2020 - 2030 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- Japan
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- GCC
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Technique, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutics Technique, 2020 - 2030 (USD Million)
- Brazil
- North America
- Global Nonalcoholic Steatohepatitis (NASH) Diagnostics and Therapeutics Market, By Pipeline Therapeutics, 2020 - 2030 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- AstraZeneca PLC
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Conatus Pharmaceuticals, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Enzo Biochem, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Galmed Pharmaceuticals Ltd
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Genfit Corp.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Gilead
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Horizon Pharma PLC
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Immuron
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Intercept Pharmaceuticals, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Novo Nordisk A/S
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- AstraZeneca PLC
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2023, the Global Nuclear Medicine Diagnostics (SPECT and PET) Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Open System Magnetic Resonance Imaging (MRI) Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Ophthalmic Surgical Instruments Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Organ Preservation Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%